FISERV INC — Financial Data
Annual figures from SEC EDGAR XBRL filings (10-K)
These figures are extracted directly from XBRL-tagged financial statements that FISERV INC filed with the SEC as part of its annual 10-K reports. XBRL (eXtensible Business Reporting Language) is a structured data format the SEC requires for machine-readable financial disclosures. Values shown are as reported — negative figures indicate a loss and are shown in red.
Revenue
Total revenue from all business activities — the top line of the income statement. Represents all money earned before any expenses are deducted.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $21.19B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $20.46B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $19.09B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $17.74B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $16.23B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $14.85B | Feb 23, 2023 |
| FY2018 | Dec 31, 2018 | $1.55B | Feb 21, 2019 |
| FY2018 | Sep 30, 2018 | $1.41B | Feb 21, 2019 |
| FY2018 | Jun 30, 2018 | $1.42B | Feb 21, 2019 |
| FY2018 | Mar 31, 2018 | $1.44B | Feb 21, 2019 |
Revenue
Revenue recognized from contracts with customers under ASC 606, excluding taxes collected on behalf of government authorities. This is the primary revenue concept for many companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2021 | Dec 31, 2021 | $16.23B | Feb 24, 2022 |
| FY2020 | Dec 31, 2020 | $3.83B | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $3.79B | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $3.47B | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $3.77B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $4.05B | Feb 26, 2021 |
| FY2020 | Sep 30, 2019 | $3.13B | Feb 26, 2021 |
| FY2020 | Jun 30, 2019 | $1.51B | Feb 26, 2021 |
| FY2020 | Mar 31, 2019 | $1.50B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $1.55B | Feb 27, 2020 |
Net Income
The bottom-line profit — what remains after all operating expenses, interest, taxes, and other costs are deducted. A negative value means the company reported a net loss for the year.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.48B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $3.13B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $3.07B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $2.53B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.33B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $300.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $264.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $2.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $392.00M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $247.00M | Feb 26, 2021 |
Operating Income
Profit from core business operations before interest expense and income taxes (also known as EBIT). Excludes non-operating items, making it a cleaner measure of operational efficiency than net income.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $5.82B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $5.88B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $5.01B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $3.74B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $2.29B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $516.00M | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $542.00M | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $165.00M | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $629.00M | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $478.00M | Feb 26, 2021 |
SG&A Expense
Selling, general, and administrative expenses — the overhead costs of running the business, including salaries, marketing, legal fees, and corporate office costs. Excludes COGS and R&D.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.88B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.56B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $6.58B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $6.06B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $5.81B | Feb 22, 2024 |
| FY2020 | Dec 31, 2020 | $1.46B | Feb 26, 2021 |
| FY2020 | Sep 30, 2020 | $1.41B | Feb 26, 2021 |
| FY2020 | Jun 30, 2020 | $1.38B | Feb 26, 2021 |
| FY2020 | Mar 31, 2020 | $1.40B | Feb 26, 2021 |
| FY2020 | Dec 31, 2019 | $1.46B | Feb 26, 2021 |
Operating Cash Flow
Cash generated from core business operations — a more reliable measure of financial health than net income because it strips out non-cash items like depreciation and one-time charges.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $6.06B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $6.63B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $5.16B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $4.62B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $4.03B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $4.15B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $2.80B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $1.55B | Feb 26, 2021 |
Capital Expenditures (Capex)
Cash spent on acquiring or upgrading physical assets — property, equipment, and infrastructure. High capex businesses include manufacturing, telecom, and energy companies.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $1.76B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.57B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.39B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $1.48B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $1.16B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $900.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $721.00M | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $360.00M | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $287.00M | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $290.00M | Feb 21, 2019 |
Total Assets
The total value of everything the company owns or controls — cash, investments, receivables, property, equipment, and intangibles. Reported as of fiscal year end.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $80.13B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $77.18B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $90.89B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $83.87B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $76.25B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $74.62B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $77.54B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $11.26B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $10.29B | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $9.74B | Feb 21, 2019 |
Total Liabilities
All financial obligations owed to outside parties — including debt, accounts payable, accrued expenses, and deferred revenue. Subtracting liabilities from total assets gives stockholders' equity.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $54.32B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $49.49B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $60.22B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $52.18B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $44.30B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $41.29B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $42.68B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $8.97B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $7.56B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $7.20B | Feb 22, 2018 |
Stockholders Equity
The net worth attributable to shareholders: total assets minus total liabilities. Also called book value. Can be negative if liabilities exceed assets, which is common in capital-intensive industries.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $25.79B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $27.07B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $29.86B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $30.83B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $30.95B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $32.33B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $32.98B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $2.29B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $2.73B | Feb 21, 2019 |
| FY2018 | Dec 31, 2016 | $2.54B | Feb 21, 2019 |
Goodwill
An intangible asset representing the premium paid above fair value when acquiring another company. A large goodwill balance signals a history of acquisitions at premium prices.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $37.70B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $36.58B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $37.21B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $36.81B | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $36.43B | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $36.32B | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $36.04B | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | $5.70B | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | $5.59B | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | $5.37B | Feb 21, 2019 |
Retained Earnings
Cumulative net income kept by the company rather than distributed as dividends. A growing retained earnings balance indicates consistent profitability; a deficit indicates cumulative losses.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $27.06B | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $23.58B | Feb 19, 2026 |
| FY2024 | Dec 31, 2023 | $20.44B | Feb 20, 2025 |
| FY2023 | Dec 31, 2022 | $17.38B | Feb 22, 2024 |
| FY2022 | Dec 31, 2021 | $14.85B | Feb 23, 2023 |
| FY2021 | Dec 31, 2020 | $13.44B | Feb 24, 2022 |
| FY2020 | Dec 31, 2019 | $12.53B | Feb 26, 2021 |
| FY2019 | Dec 31, 2018 | $11.64B | Feb 27, 2020 |
| FY2018 | Dec 31, 2017 | $10.24B | Feb 21, 2019 |
| FY2017 | Dec 31, 2016 | $8.99B | Feb 22, 2018 |
Cash & Equivalents
Highly liquid assets the company holds — cash on hand, bank balances, and short-term investments with maturities of three months or less. A key indicator of short-term financial health.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $798.00M | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | $1.24B | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | $1.20B | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | $902.00M | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | $835.00M | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | $906.00M | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | $893.00M | Feb 24, 2022 |
| FY2013 | Dec 31, 2013 | $400.00M | Feb 20, 2014 |
| FY2013 | Dec 31, 2012 | $358.00M | Feb 20, 2014 |
| FY2013 | Dec 31, 2011 | $337.00M | Feb 20, 2014 |
Long-Term Debt
Debt obligations due more than one year from the balance sheet date — bonds, term loans, and notes payable. High long-term debt relative to equity can signal elevated financial leverage.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2012 | Dec 31, 2012 | $3.23B | Feb 22, 2013 |
| FY2011 | Dec 31, 2011 | $3.40B | Feb 24, 2012 |
| FY2010 | Dec 31, 2010 | $3.36B | Feb 24, 2011 |
| FY2010 | Dec 31, 2009 | $3.64B | Feb 24, 2011 |
EPS (Basic)
Net income divided by the weighted average shares outstanding. Basic EPS does not account for dilutive securities like options or convertible bonds — use diluted EPS for a more conservative view.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 5 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 2 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 21, 2019 |
EPS (Diluted)
Net income divided by the fully diluted share count — including all potential shares from options, warrants, and convertible instruments. The more conservative and widely cited EPS figure.
| Fiscal Year | Period End | Value | Filed |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 6 | Feb 19, 2026 |
| FY2025 | Dec 31, 2024 | 5 | Feb 19, 2026 |
| FY2025 | Dec 31, 2023 | 4 | Feb 19, 2026 |
| FY2024 | Dec 31, 2022 | 3 | Feb 20, 2025 |
| FY2023 | Dec 31, 2021 | 1 | Feb 22, 2024 |
| FY2022 | Dec 31, 2020 | 1 | Feb 23, 2023 |
| FY2021 | Dec 31, 2019 | 1 | Feb 24, 2022 |
| FY2020 | Dec 31, 2018 | 2 | Feb 26, 2021 |
| FY2019 | Dec 31, 2017 | 2 | Feb 27, 2020 |
| FY2018 | Dec 31, 2016 | 2 | Feb 21, 2019 |